ArticlePathology oncology research : POR2013

The non-crosslinking fixative RCL2®-CS100 is compatible with both pathology diagnosis and molecular analyses.

Florence Boissière-Michot et al.PubMed ↗Publisher ↗

No numbers read from the abstract.